首页|基于CRISPR/Cas9技术构建SLC19A2基因敲除小鼠及其表型验证

基于CRISPR/Cas9技术构建SLC19A2基因敲除小鼠及其表型验证

扫码查看
目的 利用CRISPR/Cas9技术构建SLC19A2基因敲除的纯合子小鼠模型,并验证其表型。方法 设计gRNA载体,将构建好的gRNA载体和Cas9载体进行体外转录后共注射到受精卵,经胚胎移植后获得6只(雌性3只、雄性3只)阳性F0代小鼠。通过繁育获得12只(雄性6只、雌性6只)SLC19A2基因敲除纯合子小鼠[SLC19A2-/-小鼠(C57BL/6)]。8周龄野生型C57BL/6小鼠和SLC19A2-/-小鼠各12只(雄性6只、雌性6只),分别设为野生型组与基因敲除纯合子组。采用PCR扩增凝胶电泳法鉴定小鼠基因型;采用实时荧光定量PCR检测胰腺组织和肝脏组织中SLC19A2 mRNA表达,采用蛋白质印迹法检测胰腺组织和肝脏组织中THTR-1蛋白表达。结果 PCR扩增凝胶电泳法成功鉴定出SLC19A2-/-小鼠。基因敲除纯合子组胰腺组织和肝脏组织中SLC19A2 mRNA及THTR-1蛋白表达水平低于野生型组,差异有统计学意义(P<0。05)。结论 基于CRISPR/Cas9技术成功构建了 SLC19A2基因敲除小鼠。
Construction of SLC19A2 knockout mice based on CRISPR/Cas9 techno-logy and its phenotypic validation
Objective To construct a purebred mouse model of SLC19A2 knockout using CRISPR/Cas9 technology and validate its phenotype.Methods The gRNA vectors were designed,and the constructed gRNA vectors and Cas9 vectors were co-injected into fertilised eggs after in vitro transcription,and six(three females and three males)positive F0 generation mice were obtained after embryo transfer.Twelve(six males and six females)SLC19A2 knockout purebred mice[SLC19A2-/-mice(C57BL/6)]were obtained by breeding.Twelve wild-type C57BL/6 mice and twelve SLC19A2-/-mice(six males and six females)each at eight weeks of age were set up as the wild-type group and the knockout pureblood group,respectively.Mouse genotypes were identified by PCR amplification gel electrophoresis;SLC19A2 mRNA expression in pancreatic and liver tissues was detected by real-time fluorescence quantitative PCR,and THTR-1 protein expression in pancreatic and liver tissues was detected by Western blot.Results SLC 19A2 mice were successfully identified by PCR amplification gel electrophoresis.The expression levels of SLC 19A2 mRNA and THTR-1 protein in pancreatic tissues and liver tissues of the knockout pureblood group were lower than those of the wild-type group,and the differences were statistically significant(P<0.05).Conclusion SLC19A2 knockout mice were successfully constructed based on CRISPR/Cas9 technology.

SLC19A2KnockoutCRISPR/Cas9

钱晨、向利群、覃媛媛、闫婕、赵安然、叶玉萍、林发全

展开 >

广西医科大学第一附属医院检验科广西高校临床检验诊断学重点实验室,广西南宁 530021

SLC19A2 基因敲除 CRISPR/Cas9

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(22)